rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Dr. Reddy's Laboratories Ltd.

500124 DRREDDY Group (A)

30 Aug,15:54
7029.20
92.35 (1.33%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Dr. Reddy's Laboratories Ltd.

BUYSELL

9,477 6,936.85 7,042.05 - 6,938.60 7,101.00 - 5,212.10 117,317.35
NSE | BSE

Dr. Reddy's Laboratories Ltd.

DRREDDY

30 Aug,15:59
7031.35
100.20 (1.45%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Dr. Reddy's Laboratories Ltd.

BUYSELL

683,042 6931.15 7,045.00 - 6,938.00 7,107.45 - 5,205.55 4,793,527,282.22
(Rs. Crore)

Financial Results of Dr. Reddy's Laboratories Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales19,483.8016,962.5014,405.2013,349.1011,850.40
Operating profit5,926.404,214.802,594.103,136.802,869.60
Interest21.8016.9038.0046.7047.80
Gross profit6,766.904,789.203,038.103,891.203,565.00
EPS (Rs)260.31156.8397.55131.39176.76

See more in Research Center »

About Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology. Wikipedia

News for Pharmaceuticals and health care

India's Trade...
India's Trade Surplus & Deficit: 151 Nations, 75 Countries (Jan-June 2024)
GTRI reports India had a trade surplus with 151 countries & deficit with 75, including China & Russia, during Jan-June 2024. Key focus on reducing industrial goods imports.
Sep 01, 2024 11:10
FPI Inflow in...
FPI Inflow in Indian Equities Drops to Rs 7,320 cr in August
Foreign portfolio investors (FPIs) invested Rs 7,320 crore in Indian equities in August, down from Rs 32,365 crore in July. High valuations and the unwinding of the Yen carry trade were cited as...
Sep 01, 2024 10:49
PVR INOX to Close...
PVR INOX to Close Screens, Monetize Assets: FY25 Plans
PVR INOX plans to close 70 non-performing screens in FY25, focusing on profitable growth. The company also plans to monetize real estate assets in key locations.
Sep 01, 2024 10:40
Top 10 Indian...
Top 10 Indian Firms Mcap Surges Rs 1.53 Lakh Crore: Airtel, Infosys Lead
Eight of the top-10 most valued Indian firms saw their market valuations surge by Rs 1.53 lakh crore last week, with Bharti Airtel and Infosys emerging as the biggest gainers.
Sep 01, 2024 10:30
Stock Market...
Stock Market Outlook: Global Trends, Macro Data, FPI Activity Key
Market sentiments will be driven by global trends, macro data, FPI activity, US interest rates, and auto sales data. Key indices are expected to continue their upward trend.
Sep 01, 2024 10:02

More News »

Top News

India's Trade...
India's Trade Surplus & Deficit: 151 Nations, 75 Countries (Jan-June 2024)
GTRI reports India had a trade surplus with 151 countries & deficit with 75, including China & Russia, during Jan-June 2024. Key focus on reducing industrial goods imports.
Sep 01, 2024 11:10
Bajaj Housing Finance IPO Opens Sep 9: Rs 6,560 Cr
Bajaj Housing Finance's Rs 6,560 crore IPO will open for subscription on September 9, closing on September 11. The IPO comprises a fresh issue and an offer for sale by parent Bajaj Finance.
Sep 01, 2024 10:55
FPI Inflow in...
FPI Inflow in Indian Equities Drops to Rs 7,320 cr in August
Foreign portfolio investors (FPIs) invested Rs 7,320 crore in Indian equities in August, down from Rs 32,365 crore in July. High valuations and the unwinding of the Yen carry trade were cited as...
Sep 01, 2024 10:49
PVR INOX to Close...
PVR INOX to Close Screens, Monetize Assets: FY25 Plans
PVR INOX plans to close 70 non-performing screens in FY25, focusing on profitable growth. The company also plans to monetize real estate assets in key locations.
Sep 01, 2024 10:40
Restaurant Sector Expected to Rebound After Tough Q1: Speciality Restaurants CMD
Speciality Restaurants CMD expects the restaurant industry to recover in India, citing strong fundamentals despite temporary challenges like food inflation. The company focuses on profitable growth...
Sep 01, 2024 10:30

More Top News »

Report Card

PE Ratios
27.00
EPS (Rs.)
260.31
Sales (Rs. Cr)
5,841.20
Face Value (Rs.)
5
Net Profit Margin (%)
22.28
Last Bonus
1:1
Last Dividend(%)
800
Return on Average Equity
17.91

Compare 'Dr. Reddy's Laboratories Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,798.45
  • Compare
  • Divi's Laboratories Ltd.
  • 5,008.05
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,434.70
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,132.25
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,855.95
  • Compare
  • Aurobindo Pharma Ltd.
  • 1,562.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 865.75
  • Compare
  • Alkem Laboratories Ltd.
  • 5,998.65
  • Compare

Most Active

  • Change (Rs.)
  •  

Dr. Reddy's Laboratories Ltd. performance snapshot

If you had invested Rs.  in Dr. Reddy's Laboratories Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Dr. Reddy's Laboratories Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Dr. Reddy's Laboratories Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close